Anna-James Bott (Anna James-Bott)

ORCID

Publication Activity (10 Years)

Years Active: 2023-2023
Publications (10 Years): 15

Top Venues

Blood cancer journal

Blood advances

This page only lists publications with an associated author ORCID identifier.

Publications

Nancy Gudgeon, Hannah Victoria Giles, Emma Louise Bishop, Taylor Fulton-Ward, Cristina Escribano-Gonzalez, Haydn Munford, Anna-James Bott, Kane Foster, Farheen Karim, Dedunu Abeysekara Jayawardana, Ansar Mahmood, Adam Cribbs, Daniel A Tennant, Supratik Basu, Guy Pratt, Sarah Dimeloe
Uptake of long-chain fatty acids from the bone marrow suppresses CD8+ T-cell metabolism and function in multiple myeloma. Blood advances (2023)
Keiji Kurata, Anna-James Bott, Mark A Tye, Leona Yamamoto, Mehmet Kemal Samur, Yu-Tzu Tai, James E Dunford, Catrine Johansson, Filiz Senbabaoglu, Martin Philpott, Charlotte Palmer, Karthik Ramasamy, Sarah Gooding, Mihaela Smilova, Giorgia Gaeta, Manman Guo, John C Christianson, Neil Connor Payne, Kritika Singh, Kubra Karagoz, Matthew E Stokes, Maria Ortiz, Patrick Hagner, Anjan Thakurta, Adam Cribbs, Ralph Mazitschek, Teru Hideshima, Kenneth C Anderson, Udo Oppermann
Prolyl-tRNA synthetase as a novel therapeutic target in multiple myeloma. Blood cancer journal 13 (1) (2023)
Keiji Kurata, Anna-James Bott, Mark A Tye, Leona Yamamoto, Mehmet Kemal Samur, Yu-Tzu Tai, James E Dunford, Catrine Johansson, Filiz Senbabaoglu, Martin Philpott, Charlotte Palmer, Karthik Ramasamy, Sarah Gooding, Mihaela Smilova, Giorgia Gaeta, Manman Guo, John C Christianson, Neil Connor Payne, Kritika Singh, Kubra Karagoz, Matthew E Stokes, Maria Ortiz, Patrick Hagner, Anjan Thakurta, Adam Cribbs, Ralph Mazitschek, Teru Hideshima, Kenneth C Anderson, Udo Oppermann
Prolyl-tRNA synthetase as a novel therapeutic target in multiple myeloma. Blood cancer journal 13 (1) (2023)
Keiji Kurata, Anna-James Bott, Mark A Tye, Leona Yamamoto, Mehmet Kemal Samur, Yu-Tzu Tai, James E Dunford, Catrine Johansson, Filiz Senbabaoglu, Martin Philpott, Charlotte Palmer, Karthik Ramasamy, Sarah Gooding, Mihaela Smilova, Giorgia Gaeta, Manman Guo, John C Christianson, Neil Connor Payne, Kritika Singh, Kubra Karagoz, Matthew E Stokes, Maria Ortiz, Patrick Hagner, Anjan Thakurta, Adam Cribbs, Ralph Mazitschek, Teru Hideshima, Kenneth C Anderson, Udo Oppermann
Correction: Prolyl-tRNA synthetase as a novel therapeutic target in multiple myeloma. Blood cancer journal 13 (1) (2023)
Keiji Kurata, Anna-James Bott, Mark A Tye, Leona Yamamoto, Mehmet Kemal Samur, Yu-Tzu Tai, James E Dunford, Catrine Johansson, Filiz Senbabaoglu, Martin Philpott, Charlotte Palmer, Karthik Ramasamy, Sarah Gooding, Mihaela Smilova, Giorgia Gaeta, Manman Guo, John C Christianson, Neil Connor Payne, Kritika Singh, Kubra Karagoz, Matthew E Stokes, Maria Ortiz, Patrick Hagner, Anjan Thakurta, Adam Cribbs, Ralph Mazitschek, Teru Hideshima, Kenneth C Anderson, Udo Oppermann
Prolyl-tRNA synthetase as a novel therapeutic target in multiple myeloma. Blood cancer journal 13 (1) (2023)
Keiji Kurata, Anna-James Bott, Mark A Tye, Leona Yamamoto, Mehmet Kemal Samur, Yu-Tzu Tai, James E Dunford, Catrine Johansson, Filiz Senbabaoglu, Martin Philpott, Charlotte Palmer, Karthik Ramasamy, Sarah Gooding, Mihaela Smilova, Giorgia Gaeta, Manman Guo, John C Christianson, Neil Connor Payne, Kritika Singh, Kubra Karagoz, Matthew E Stokes, Maria Ortiz, Patrick Hagner, Anjan Thakurta, Adam Cribbs, Ralph Mazitschek, Teru Hideshima, Kenneth C Anderson, Udo Oppermann
Prolyl-tRNA synthetase as a novel therapeutic target in multiple myeloma. Blood cancer journal 13 (1) (2023)
Keiji Kurata, Anna-James Bott, Mark A Tye, Leona Yamamoto, Mehmet Kemal Samur, Yu-Tzu Tai, James E Dunford, Catrine Johansson, Filiz Senbabaoglu, Martin Philpott, Charlotte Palmer, Karthik Ramasamy, Sarah Gooding, Mihaela Smilova, Giorgia Gaeta, Manman Guo, John C Christianson, Neil Connor Payne, Kritika Singh, Kubra Karagoz, Matthew E Stokes, Maria Ortiz, Patrick Hagner, Anjan Thakurta, Adam Cribbs, Ralph Mazitschek, Teru Hideshima, Kenneth C Anderson, Udo Oppermann
Prolyl-tRNA synthetase as a novel therapeutic target in multiple myeloma. Blood cancer journal 13 (1) (2023)
Keiji Kurata, Anna-James Bott, Mark A Tye, Leona Yamamoto, Mehmet Kemal Samur, Yu-Tzu Tai, James E Dunford, Catrine Johansson, Filiz Senbabaoglu, Martin Philpott, Charlotte Palmer, Karthik Ramasamy, Sarah Gooding, Mihaela Smilova, Giorgia Gaeta, Manman Guo, John C Christianson, Neil Connor Payne, Kritika Singh, Kubra Karagoz, Matthew E Stokes, Maria Ortiz, Patrick Hagner, Anjan Thakurta, Adam Cribbs, Ralph Mazitschek, Teru Hideshima, Kenneth C Anderson, Udo Oppermann
Prolyl-tRNA synthetase as a novel therapeutic target in multiple myeloma. Blood cancer journal 13 (1) (2023)
Keiji Kurata, Anna-James Bott, Mark A Tye, Leona Yamamoto, Mehmet Kemal Samur, Yu-Tzu Tai, James E Dunford, Catrine Johansson, Filiz Senbabaoglu, Martin Philpott, Charlotte Palmer, Karthik Ramasamy, Sarah Gooding, Mihaela Smilova, Giorgia Gaeta, Manman Guo, John C Christianson, Neil Connor Payne, Kritika Singh, Kubra Karagoz, Matthew E Stokes, Maria Ortiz, Patrick Hagner, Anjan Thakurta, Adam Cribbs, Ralph Mazitschek, Teru Hideshima, Kenneth C Anderson, Udo Oppermann
Prolyl-tRNA synthetase as a novel therapeutic target in multiple myeloma. Blood cancer journal 13 (1) (2023)
Keiji Kurata, Anna-James Bott, Mark A Tye, Leona Yamamoto, Mehmet Kemal Samur, Yu-Tzu Tai, James E Dunford, Catrine Johansson, Filiz Senbabaoglu, Martin Philpott, Charlotte Palmer, Karthik Ramasamy, Sarah Gooding, Mihaela Smilova, Giorgia Gaeta, Manman Guo, John C Christianson, Neil Connor Payne, Kritika Singh, Kubra Karagoz, Matthew E Stokes, Maria Ortiz, Patrick Hagner, Anjan Thakurta, Adam Cribbs, Ralph Mazitschek, Teru Hideshima, Kenneth C Anderson, Udo Oppermann
Prolyl-tRNA synthetase as a novel therapeutic target in multiple myeloma. Blood cancer journal 13 (1) (2023)
Keiji Kurata, Anna-James Bott, Mark A Tye, Leona Yamamoto, Mehmet Kemal Samur, Yu-Tzu Tai, James E Dunford, Catrine Johansson, Filiz Senbabaoglu, Martin Philpott, Charlotte Palmer, Karthik Ramasamy, Sarah Gooding, Mihaela Smilova, Giorgia Gaeta, Manman Guo, John C Christianson, Neil Connor Payne, Kritika Singh, Kubra Karagoz, Matthew E Stokes, Maria Ortiz, Patrick Hagner, Anjan Thakurta, Adam Cribbs, Ralph Mazitschek, Teru Hideshima, Kenneth C Anderson, Udo Oppermann
Prolyl-tRNA synthetase as a novel therapeutic target in multiple myeloma. Blood cancer journal 13 (1) (2023)
Keiji Kurata, Anna-James Bott, Mark A Tye, Leona Yamamoto, Mehmet Kemal Samur, Yu-Tzu Tai, James E Dunford, Catrine Johansson, Filiz Senbabaoglu, Martin Philpott, Charlotte Palmer, Karthik Ramasamy, Sarah Gooding, Mihaela Smilova, Giorgia Gaeta, Manman Guo, John C Christianson, Neil Connor Payne, Kritika Singh, Kubra Karagoz, Matthew E Stokes, Maria Ortiz, Patrick Hagner, Anjan Thakurta, Adam Cribbs, Ralph Mazitschek, Teru Hideshima, Kenneth C Anderson, Udo Oppermann
Prolyl-tRNA synthetase as a novel therapeutic target in multiple myeloma. Blood cancer journal 13 (1) (2023)
Keiji Kurata, Anna-James Bott, Mark A Tye, Leona Yamamoto, Mehmet Kemal Samur, Yu-Tzu Tai, James E Dunford, Catrine Johansson, Filiz Senbabaoglu, Martin Philpott, Charlotte Palmer, Karthik Ramasamy, Sarah Gooding, Mihaela Smilova, Giorgia Gaeta, Manman Guo, John C Christianson, Neil Connor Payne, Kritika Singh, Kubra Karagoz, Matthew E Stokes, Maria Ortiz, Patrick Hagner, Anjan Thakurta, Adam Cribbs, Ralph Mazitschek, Teru Hideshima, Kenneth C Anderson, Udo Oppermann
Correction: Prolyl-tRNA synthetase as a novel therapeutic target in multiple myeloma. Blood cancer journal 13 (1) (2023)
Keiji Kurata, Anna-James Bott, Mark A Tye, Leona Yamamoto, Mehmet Kemal Samur, Yu-Tzu Tai, James E Dunford, Catrine Johansson, Filiz Senbabaoglu, Martin Philpott, Charlotte Palmer, Karthik Ramasamy, Sarah Gooding, Mihaela Smilova, Giorgia Gaeta, Manman Guo, John C Christianson, Neil Connor Payne, Kritika Singh, Kubra Karagoz, Matthew E Stokes, Maria Ortiz, Patrick Hagner, Anjan Thakurta, Adam Cribbs, Ralph Mazitschek, Teru Hideshima, Kenneth C Anderson, Udo Oppermann
Prolyl-tRNA synthetase as a novel therapeutic target in multiple myeloma. Blood cancer journal 13 (1) (2023)
Keiji Kurata, Anna-James Bott, Mark A Tye, Leona Yamamoto, Mehmet Kemal Samur, Yu-Tzu Tai, James E Dunford, Catrine Johansson, Filiz Senbabaoglu, Martin Philpott, Charlotte Palmer, Karthik Ramasamy, Sarah Gooding, Mihaela Smilova, Giorgia Gaeta, Manman Guo, John C Christianson, Neil Connor Payne, Kritika Singh, Kubra Karagoz, Matthew E Stokes, Maria Ortiz, Patrick Hagner, Anjan Thakurta, Adam Cribbs, Ralph Mazitschek, Teru Hideshima, Kenneth C Anderson, Udo Oppermann
Correction: Prolyl-tRNA synthetase as a novel therapeutic target in multiple myeloma. Blood cancer journal 13 (1) (2023)

Anna-James Bott.css-eqlu8i{font-size:small;padding-left:4px;} (Anna James-Bott)

Publication Activity (10 Years)

Top Topics

Top Venues

Anna-James Bott (Anna James-Bott)